These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37464124)

  • 1. Definition, Phenotyping of Severe Asthma, Including Cluster Analysis.
    Casanova S; Ahmed E; Bourdin A
    Adv Exp Med Biol; 2023; 1426():239-252. PubMed ID: 37464124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
    Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E
    Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Management of Severe Asthma.
    Chung KF
    Semin Respir Crit Care Med; 2018 Feb; 39(1):91-99. PubMed ID: 29427989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.
    Wenzel SE
    Am J Respir Crit Care Med; 2021 Apr; 203(7):809-821. PubMed ID: 33326352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, phenotypes, mechanisms and management of severe asthma.
    Chung KF; Dixey P; Abubakar-Waziri H; Bhavsar P; Patel PH; Guo S; Ji Y
    Chin Med J (Engl); 2022 May; 135(10):1141-1155. PubMed ID: 35633594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asthma in clinical practice: from inflammatory phenotypes to personalized treatment].
    Schleich F; Graff S; Bougard N; Frix AN; Peerboom S; Demarche S; Guissard F; Paulus V; Henket M; Calmès D; Moermans C; Louis R
    Rev Med Liege; 2022 May; 77(5-6):289-294. PubMed ID: 35657185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Concepts of Asthma.
    Gauthier M; Ray A; Wenzel SE
    Am J Respir Crit Care Med; 2015 Sep; 192(6):660-8. PubMed ID: 26161792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?
    Fitzpatrick AM; Moore WC
    J Allergy Clin Immunol Pract; 2017; 5(4):901-908. PubMed ID: 28689840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for severe eosinophilic asthma.
    Yancey SW; Keene ON; Albers FC; Ortega H; Bates S; Bleecker ER; Pavord I
    J Allergy Clin Immunol; 2017 Dec; 140(6):1509-1518. PubMed ID: 29221581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine in asthma: linking phenotypes to targeted treatments.
    Chung KF
    Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of severe asthma in 2020.
    Côté A; Godbout K; Boulet LP
    Biochem Pharmacol; 2020 Sep; 179():114112. PubMed ID: 32598948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies and opportunities in severe asthma.
    Humbert M; Busse W; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA).
    Bilò MB; Antonicelli L; Carone M; De Michele F; Menzella F; Musarra A; Tognella S; Vaghi A; Micheletto C
    Eur Ann Allergy Clin Immunol; 2021 May; 53(3):103-114. PubMed ID: 33728838
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of Biologics in Asthma.
    McGregor MC; Krings JG; Nair P; Castro M
    Am J Respir Crit Care Med; 2019 Feb; 199(4):433-445. PubMed ID: 30525902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.